{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:41:59Z","timestamp":1794271319447,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Project for Medical and Health Science and Technology","award":["No. 2025HY0078"],"award-info":[{"award-number":["No. 2025HY0078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08185-z","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:05:33Z","timestamp":1777111533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bispecific CD37\u2013Siglec6 CAR\u2011T cells exhibit enhanced anti\u2011leukemic activity and reduced exhaustion in acute myeloid leukemia xenograft models"],"prefix":"10.1186","volume":"24","author":[{"given":"Liping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-2604","authenticated-orcid":false,"given":"Wenwen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"8185_CR1","doi-asserted-by":"publisher","first-page":"117954","DOI":"10.1016\/j.envres.2023.117954","volume":"244","author":"AE Janitz","year":"2024","unstructured":"Janitz AE, Marcotte EL, Barr DB, Xu C, Peck JD, Campbell JE. Exposure to persistent organic pollutants in newborn dried blood spots and childhood acute myeloid leukemia. Environ Res. 2024;244:117954.","journal-title":"Environ Res"},{"issue":"6","key":"8185_CR2","doi-asserted-by":"publisher","first-page":"e2516296","DOI":"10.1001\/jamanetworkopen.2025.16296","volume":"8","author":"RJ Marrero","year":"2025","unstructured":"Marrero RJ, Shastri VM, Nicolet D, Mr\u00f3zek K, Walker CJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Uy GL, et al. Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia. JAMA Netw Open. 2025;8(6):e2516296.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"8185_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1182\/blood.2021013972","volume":"139","author":"JJ Bednarski","year":"2022","unstructured":"Bednarski JJ, Zimmerman C, Berrien-Elliott MM, Foltz JA, Becker-Hapak M, Neal CC, Foster M, Schappe T, McClain E, Pence PP, et al. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant. Blood. 2022;139(11):1670\u201383.","journal-title":"Blood"},{"issue":"11","key":"8185_CR4","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41587-023-01684-0","volume":"41","author":"A Gottschlich","year":"2023","unstructured":"Gottschlich A, Thomas M, Gr\u00fcnmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, et al. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. Nat Biotechnol. 2023;41(11):1618\u201332.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"8185_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1182\/blood.2024024072","volume":"144","author":"N Hassan","year":"2024","unstructured":"Hassan N, Yi H, Malik B, Gaspard-Boulinc L, Samaraweera SE, Casolari DA, Seneviratne J, Balachandran A, Chew T, Duly A, et al. Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4\/HOXA9-dependent AML. Blood. 2024;144(1):84\u201398.","journal-title":"Blood"},{"issue":"1","key":"8185_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han L, Dong L, Leung K, Zhao Z, Li Y, Gao L, Chen Z, Xue J, Qing Y, Li W, et al. METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell. 2023;30(1):52\u201368.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"8185_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","volume":"30","author":"S Beneyto-Calabuig","year":"2023","unstructured":"Beneyto-Calabuig S, Merbach AK, Kniffka JA, Antes M, Szu-Tu C, Rohde C, Waclawiczek A, Stelmach P, Gr\u00e4\u00dfle S, Pervan P, et al. Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia. Cell Stem Cell. 2023;30(5):706\u201321.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"8185_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/2159-8290.CD-22-0939","volume":"13","author":"A Waclawiczek","year":"2023","unstructured":"Waclawiczek A, Lepp\u00e4 AM, Renders S, Stumpf K, Reyneri C, Betz B, Janssen M, Shahswar R, Donato E, Karpova D, et al. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine\/Venetoclax. Cancer Discov. 2023;13(6):1408\u201327.","journal-title":"Cancer Discov"},{"issue":"10","key":"8185_CR9","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth AI, Althoff MJ, Tolison H, Engel K, Amaya ML, Krug AE, Young TN, Minhajuddin M, Pei S, Patel SB, et al. Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium. Cancer Discov. 2024;14(10):1922\u201339.","journal-title":"Cancer Discov"},{"issue":"3","key":"8185_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nm.4478","volume":"24","author":"Y Kagoya","year":"2018","unstructured":"Kagoya Y, Tanaka S, Guo T, Anczurowski M, Wang CH, Saso K, Butler MO, Minden MD, Hirano N. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nat Med. 2018;24(3):352\u20139.","journal-title":"Nat Med"},{"issue":"544","key":"8185_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1126\/scisignal.aat6753","volume":"11","author":"AI Salter","year":"2018","unstructured":"Salter AI, Ivey RG, Kennedy JJ, Voillet V, Rajan A, Alderman EJ, Voytovich UJ, Lin C, Sommermeyer D, Liu L, et al. Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci Signal. 2018;11(544):20\u201332.","journal-title":"Sci Signal"},{"key":"8185_CR12","doi-asserted-by":"publisher","first-page":"102268","DOI":"10.1016\/j.eclinm.2023.102268","volume":"65","author":"V Barsan","year":"2023","unstructured":"Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, et al. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine. 2023;65:102268.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"8185_CR13","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.ccell.2023.09.010","volume":"41","author":"S Haubner","year":"2023","unstructured":"Haubner S, Mansilla-Soto J, Nataraj S, Kogel F, Chang Q, de Stanchina E, Lopez M, Ng MR, Fraser K, Subklewe M, et al. Cooperative CAR targeting to selectively eliminate AML and minimize escape. Cancer Cell. 2023;41(11):1871\u201391.","journal-title":"Cancer Cell"},{"issue":"1","key":"8185_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00262-024-03847-7","volume":"74","author":"H Ma","year":"2024","unstructured":"Ma H, Yan Z, Gu R, Xu Y, Qiu S, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J. Loop33 \u00d7 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia. Cancer Immunol Immunother. 2024;74(1):20\u201332.","journal-title":"Cancer Immunol Immunother"},{"issue":"28","key":"8185_CR15","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1200\/JCO.20.03048","volume":"39","author":"JA Pollard","year":"2021","unstructured":"Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, et al. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children\u2019s Oncology Group Trial AAML0531. J Clin Oncol. 2021;39(28):3149\u201360.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8185_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41392-024-02096-5","volume":"10","author":"P Wang","year":"2025","unstructured":"Wang P, Wang Y, Zhao X, Zheng R, Zhang Y, Meng R, Dong H, Liang S, He X, Song Y, et al. Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells. Signal Transduct Target Ther. 2025;10(1):20\u201332.","journal-title":"Signal Transduct Target Ther"},{"key":"8185_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.omtm.2020.06.024","volume":"18","author":"JM Riberdy","year":"2020","unstructured":"Riberdy JM, Zhou S, Zheng F, Kim YI, Moore J, Vaidya A, Throm RE, Sykes A, Sahr N, Bonifant CL, et al. The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing. Mol Ther Methods Clin Dev. 2020;18:571\u201381.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"8185_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-022-01308-1","volume":"15","author":"X Jin","year":"2022","unstructured":"Jin X, Zhang M, Sun R, Lyu H, Xiao X, Zhang X, Li F, Xie D, Xiong X, Wang J, et al. First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed\/refractory acute myeloid leukemia. J Hematol Oncol. 2022;15(1):88\u201397.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"8185_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jitc-2025-013024","volume":"13","author":"M Sponheimer","year":"2025","unstructured":"Sponheimer M, White K, Ulrich M, Kazerani M, Maiser A, Tyborski ET, Rappa GP, Richter D, Briem E, H\u00e4nel G, et al. TNF-\u03b1 and IFN-\u03b3 differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity. J Immunother Cancer. 2025;13(12):8.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"8185_CR20","doi-asserted-by":"publisher","first-page":"101572","DOI":"10.1016\/j.xcrm.2024.101572","volume":"5","author":"B Caulier","year":"2024","unstructured":"Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, et al. CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. Cell Rep Med. 2024;5(6):101572.","journal-title":"Cell Rep Med"},{"issue":"8","key":"8185_CR21","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1182\/bloodadvances.2021005717","volume":"6","author":"F Buccisano","year":"2022","unstructured":"Buccisano F, Palmieri R, Piciocchi A, Arena V, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, et al. ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. Blood Adv. 2022;6(8):2510\u20136.","journal-title":"Blood Adv"},{"issue":"10","key":"8185_CR22","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/s41375-025-02697-1","volume":"39","author":"TB Heavican-Foral","year":"2025","unstructured":"Heavican-Foral TB, Korell F, Scarf\u00f2 I, Wiggers CRM, Eisenbies BAT, Powers Z, Hegel F, Liu J, Kulp J. Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma. Leukemia. 2025;39(10):2452\u201364.","journal-title":"Leukemia"},{"issue":"1","key":"8185_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaci.2022.07.018","volume":"151","author":"D Smiljkovic","year":"2023","unstructured":"Smiljkovic D, Herrmann H, Sadovnik I, Gamperl S, Berger D, Stefanzl G, Eisenwort G, Hoermann G, Kopanja S, Dorofeeva Y, et al. Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils. J Allergy Clin Immunol. 2023;151(1):202\u201311.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"8185_CR24","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/s41375-021-01188-3","volume":"35","author":"D Kovalovsky","year":"2021","unstructured":"Kovalovsky D, Yoon JH, Cyr MG, Simon S, Voynova E, Rader C, Wiestner A, Alejo J, Pittaluga S, Gress RE. Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia. Leukemia. 2021;35(9):2581\u201391.","journal-title":"Leukemia"},{"issue":"19","key":"8185_CR25","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/blood.2020009192","volume":"138","author":"H Jetani","year":"2021","unstructured":"Jetani H, Navarro-Bail\u00f3n A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, Gonz\u00e1lez M, Rial Saborido J, Kraus S, et al. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Blood. 2021;138(19):1830\u201342.","journal-title":"Blood"},{"issue":"1","key":"8185_CR26","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/s41467-024-48678-3","volume":"15","author":"J Nunes","year":"2024","unstructured":"Nunes J, Tafesse R, Mao C, Purcell M, Mo X, Zhang L, Long M, Cyr MG, Rader C, Muthusamy N. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia. Nat Commun. 2024;15(1):5180\u201391.","journal-title":"Nat Commun"},{"issue":"3","key":"8185_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1158\/2159-8290.CD-22-0964","volume":"13","author":"SM Larson","year":"2023","unstructured":"Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, et al. CD19\/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive\/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Discov. 2023;13(3):580\u201397.","journal-title":"Cancer Discov"},{"issue":"1","key":"8185_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13045-021-01170-7","volume":"14","author":"H Mei","year":"2021","unstructured":"Mei H, Li C, Jiang H, Zhao X, Huang Z, Jin D, Guo T, Kou H, Liu L, Tang L, et al. A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma. J Hematol Oncol. 2021;14(1):161\u201372.","journal-title":"J Hematol Oncol"},{"issue":"16","key":"8185_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1172\/jci.insight.140179","volume":"5","author":"JK Bailur","year":"2020","unstructured":"Bailur JK, McCachren SS, Pendleton K, Vasquez JC, Lim HS, Duffy A, Doxie DB, Kaushal A, Foster C, DeRyckere D, et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight. 2020;5(16):125\u201335.","journal-title":"JCI Insight"},{"issue":"1","key":"8185_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, Wang H, Li T, Wang C. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(1):1425\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"8185_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ccell.2022.04.001","volume":"40","author":"MB Leick","year":"2022","unstructured":"Leick MB, Silva H, Scarf\u00f2 I, Larson R, Choi BD, Bouffard AA, Gallagher K, Schmidts A, Bailey SR, Kann MC, et al. Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. 2022;40(5):494\u2013508.","journal-title":"Cancer Cell"},{"issue":"1","key":"8185_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40164-024-00592-6","volume":"14","author":"R Huang","year":"2025","unstructured":"Huang R, Wang X, Yan H, Tan X, Ma Y, Wang M, Han X, Liu J, Gao L, Gao L, et al. Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed\/refractory AML: preclinical evaluation and phase I trial. Exp Hematol Oncol. 2025;14(1):132\u201345.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"8185_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-025-01764-5","volume":"18","author":"X Zhang","year":"2025","unstructured":"Zhang X, Lu W, Zhang W, He X, Zhang Y, Jin X, Zhang M, Wang Y, Guan X, Zhang R, et al. Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed\/refractory acute myeloid leukemia. J Hematol Oncol. 2025;18(1):112\u201321.","journal-title":"J Hematol Oncol"},{"key":"8185_CR34","doi-asserted-by":"publisher","first-page":"1716317","DOI":"10.3389\/fimmu.2025.1716317","volume":"16","author":"J Meng","year":"2025","unstructured":"Meng J, Lyu H, Wang Z, Bai X, Zhu H, Pu Y, He X, Xiao X, Zhao M. Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies. Front Immunol. 2025;16:1716317.","journal-title":"Front Immunol"},{"issue":"1","key":"8185_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/bloodadvances.2024013590","volume":"9","author":"E Jeremy","year":"2025","unstructured":"Jeremy E, Artiga E, Elgamal S, Cheney C, Eicher D, Zalponik K, Orwick S, Mao C, Wasmuth R, Harrington B, et al. CD37 in acute myeloid leukemia: a novel surface target for drug delivery. Blood Adv. 2025;9(1):1\u201314.","journal-title":"Blood Adv"},{"issue":"1","key":"8185_CR36","doi-asserted-by":"publisher","first-page":"18611","DOI":"10.1038\/s41598-025-00456-x","volume":"15","author":"Q Li","year":"2025","unstructured":"Li Q, Lin L, Gao S, Chen L, Zhang Z, Ma J, Liu S, Cao Z, Zhao H, Wang Y. Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation. Sci Rep. 2025;15(1):18611.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08185-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:52:49Z","timestamp":1781139169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08185-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8185"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08185-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Hangzhou Medical College, and conducted in accordance with the National Guidelines for Laboratory Animal Welfare (GB\/T 35892\u2009\u2212\u20092018, China). All mice model experimental procedures were approved by the Institutional Animal Care and Use Committee of Hangzhou Medical College and all procedures were in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"758"}}